PRESS RELEASE published on 06/04/2024 at 18:36, 3 months 14 days ago Original-Research: Vita 34 AG (von Montega AG): Halten Vita 34 AG steigert Umsatz in Q1 um 3,6% auf 18,6 Mio. EUR. Montega AG empfiehlt Halten mit Kursziel 6,00 EUR. Analyse von Tim Kruse (CFA). Lizenzverfahren CAR-T bleibt offen Montega AG Vita 34 AG Umsatzsteigerung Halten Lizenzverfahren CAR-T
BRIEF published on 05/31/2024 at 08:38, 3 months 18 days ago Vita 34 annonce des augmentations significatives de ses bénéfices et de ses flux de trésorerie Hausse Des Revenus BAIIA Résultats Du Premier Trimestre 2024 Vie 34 Flux De Trésorerie Opérationnel
BRIEF published on 05/31/2024 at 08:38, 3 months 18 days ago Vita 34 Reports Significant Increases in Earnings and Cash Flow EBITDA Revenue Growth Operating Cash Flow Q1 2024 Earnings Vita 34
PRESS RELEASE published on 05/31/2024 at 08:33, 3 months 18 days ago Vita 34 significantly increases earnings and operating cash flow in the first quarter Vita 34 AG reports a significant increase in earnings and operating cash flow in the first quarter of 2024, with revenues up by 3.6% to EUR 18.6 million. EBITDA exceeds EUR 1.5 million Revenues Business Development Earnings Operating Cash Flow Vita 34 AG
BRIEF published on 04/30/2024 at 22:56, 4 months 18 days ago Vita 34 Sees Financial Growth and Improvement in 2023 Investment Strategies 2024 Outlook Vita 34 AG Financial Growth Increase In EBITDA
BRIEF published on 04/30/2024 at 22:56, 4 months 18 days ago Vita 34 connaît une croissance et une amélioration financières en 2023 Croissance Financière Perspectives 2024 Vita 34 AG Stratégies D'investissement Augmentation De L'EBITDA
PRESS RELEASE published on 04/30/2024 at 22:51, 4 months 18 days ago Vita 34 returns to growth path in 2023 Vita 34 AG reports 11.8% revenue growth to EUR 77.1 million in 2023 despite challenging environment. EBITDA significantly improved to EUR 5.6 million EBITDA Revenue Growth Business Development Vita 34 AG Cell Bank
BRIEF published on 04/19/2024 at 12:33, 4 months 29 days ago Vita 34 obtient des résultats financiers meilleurs que prévu pour 2023 Performance Financière Vita 34 AG Hausse Des Revenus BAIIA Rapport Sur Les Revenus
BRIEF published on 04/19/2024 at 12:33, 4 months 29 days ago Vita 34 Achieves Better Than Expected Financial Results for 2023 EBITDA Revenue Growth Financial Performance Earnings Report Vita 34 AG
PRESS RELEASE published on 04/19/2024 at 12:28, 4 months 29 days ago EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Vita 34 AG exceeds 2023 earnings expectations with EUR 5.6 million EBITDA, forecasts revenues of EUR 81-88 million and EBITDA of EUR 6.5-8.0 million for 2024 Revenues EBITDA Forecast Earnings Vita 34 AG
Published on 09/18/2024 at 23:10, 4 hours 9 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 19 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 6 hours 4 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 19 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 49 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 8 hours 8 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 47 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 9 hours 5 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 57 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 33 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 33 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 39 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.